Minoryx Therapeutics Appoints Chair
This article was originally published in Scrip
Minoryx Therapeutics, a company focused on orphan diseases, has appointed Dr. Khalid Islam chair of the company's board of directors. Islam has 27 years' experience in the pharma and biotech industry and was previously chair and CEO of Gentium S.p.a and previously he was president and CEO of Arpida AG. Prior to this, he worked in academia at Imperial College (University of London) and at Milan University, where he was a contract professor.
Register for our free email digests: